Irrimax Corporation

Irrimax Corporation, a wholly-owned subsidiary of Innovation Technologies, Inc., is dedicated to reducing infections, healthcare costs, and improving patient outcomes. The company holds rights to U.S. and global patents that provide broad protection for the use of low-concentration CHG (below 1%) technology. Its flagship product, Irrisept Antimicrobial Wound Irrigation, is a disposable, manually operated, self-contained irrigation device composed of 0.05% chlorhexidine gluconate (CHG) and 99.95% sterile irrigation water.